Moraes, R. et al. 2019. Prevalence of Neuropsychiatric Adverse Effects in HIV Patients Treated with Dolutegravir. Internal Medicine. 26, 1 (Mar. 2019), 14–20. DOI:https://doi.org/10.24950/rspmi/original/64/1/2019.